Genpact (G) is trading lower as the market digests balance-sheet mechanics around its $350 million 1.750% senior notes due 2026, which were scheduled to mature on April 10, 2026. With the shares pressing into fresh 52-week-low territory, the downside move is being reinforced by momentum-driven selling and risk reduction rather than a single headline catalyst. (sec.gov)

In its annual filing, Genpact disclosed that the 2026 Notes were $349.8 million outstanding (net of amortization) at year-end 2025 and payable at maturity on April 10, 2026. Separately, the company previously issued $350 million of 4.950% senior notes due 2030 and indicated proceeds could be used for general corporate purposes including repaying or redeeming the 2026 Notes, keeping investor attention on near-term cash uses and refinancing costs. (sec.gov)

The stock’s move comes as Genpact has already been under pressure, with the shares recently touching a 52-week low around the mid-$34 range. The next incremental drivers are likely to be any company update confirming how the maturity was handled (cash repayment vs. refinancing), plus whether management signals changes to capital allocation priorities after the note maturity clears. (investing.com)